Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 3
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic...
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA...
Psychedelic Churches Need Psychedelic Seminaries
Tell the FDA What Psychedelic Care Should Look Like. You Have...
When Psychedelic Experiences Turn into Crisis, Training Can Make All the...
Weekly Psychedelic Policy Briefing: September 30th, 2026
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets...
Load more